Related Experiment Video
Updated: Jun 23, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus
Masanao Murakami1, Rajeev Kaul, Pankaj Kumar
1Department of Microbiology and Tumor Virology Program of Abramson Comprehensive Cancer Center, University of Pennsylvania School of Medicine, 201E Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA.
Nm23-H1, a metastasis suppressor, is disrupted by Epstein-Barr virus (EBV) antigens EBNA3C and EBNA1. This interaction impacts cell proliferation and migration, contributing to EBV pathogenesis.
Area of Science:
- Oncology
- Virology
- Cell Biology
Background:
- Nm23-H1 is a known metastasis suppressor gene involved in cancer progression.
- Epstein-Barr virus (EBV) nuclear antigens EBNA3C and EBNA1 play roles in viral replication and cell proliferation.
Purpose of the Study:
- To investigate the interaction between Nm23-H1 and EBV nuclear antigens EBNA3C and EBNA1.
- To understand the functional significance of this interaction in EBV pathogenesis.
Main Methods:
- The study focuses on the molecular mechanisms underlying the interaction between Nm23-H1 and EBNA3C/EBNA1.
- Functional assays were employed to assess the impact on cell proliferation and migration.
Main Results:
- EBNA3C and EBNA1 target and disrupt the normal function of Nm23-H1.
- This disruption affects cellular processes crucial for metastasis, including cell proliferation and migration.
Conclusions:
- The interaction between Nm23-H1 and EBV antigens is a key factor in EBV-associated pathogenesis.
- Targeting this interaction could offer new therapeutic strategies for EBV-related cancers.
More Related Videos
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
09:38Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
Published on: June 26, 2019
Related Concept Videos
Antiviral Nucleoside Inhibitors
Long-patch Base Excision Repair
Subviral Agents